Dose-related effect of statins in venous thrombosis risk reduction

American Journal of Medicine

Volumn 124, Issue 9, 2011, Pages 852-859

  Khemasuwan, Danai ^a   Chae, Young Kwang ^a   Gupta, Shikha ^a   Carpio, Alejandra ^a   Yun, Jeong Hyun ^a   Neagu, Stefan ^a   Lucca, Anabella B ^a   Valsecchi, Matias E ^b   Mora, Jorge I ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Antiplatelet therapy; Atherosclerosis; Deep vein thrombosis; Pulmonary embolism; Statins; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CLOPIDOGREL; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COHORT ANALYSIS; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; TEACHING HOSPITAL; VEIN THROMBOSIS;

AGED; ASPIRIN; ATHEROSCLEROSIS; CEREBRAL INFARCTION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK REDUCTION BEHAVIOR; TICLOPIDINE; VENOUS THROMBOEMBOLISM;

EID: 80052036324     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.04.019     Document Type: Article

References (37)

1. G. Piazza, and S.Z. Goldhaber Venous thromboembolism and atherothrombosis: an integrated approach Circulation 121 2010 2146 2150
2. H.G. Rus, R. Vlaicu, and F. Niculescu Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall Atherosclerosis 127 1996 263 271 (Pubitemid 27045840)
3. H.G. Rus, F. Niculescu, and R. Vlaicu Tumor necrosis factor-alpha in human arterial wall with atherosclerosis Atherosclerosis 89 1991 247 254
4. B.E. van Aken, P.H. Reitsma, and F.R. Rosendaal Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis Br J Haematol 116 2002 173 177 (Pubitemid 34122078)
5. B.E. van Aken, M. den Heijer, and G.M. Bos Recurrent venous thrombosis and markers of inflammation Thromb Haemost 83 2000 536 539 (Pubitemid 30201126)
6. H.T. Sørensen, E. Horvath-Puho, and L. Pedersen Venous thromboembolism and subsequent hospitalization due to acute arterial cardiovascular events: a 20-year cohort study Lancet 370 2007 1773 1779 (Pubitemid 350137491)
7. H.T. Sorensen, E. Horvath-Puho, and K.K. Sogaard Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study J Thromb Haemost 7 2009 521 528
8. W. Ageno, C. Becattini, and T. Brighton Cardiovascular risk factors and venous thromboembolism: a meta-analysis Circulation 117 2008 93 102 (Pubitemid 350301144)
9. W. Ageno, P. Prandoni, and E. Romualdi The metabolic syndrome and the risk of venous thrombosis: a case-control study J Thromb Haemost 4 2006 1914 1918 (Pubitemid 44226768)
10. F. Sofi, R. Marcucci, and R. Abbate Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis Am J Med 120 2007 728 733 (Pubitemid 47189658)
11. S. Eichinger, N.M. Pecheniuk, and G. Hron High-density lipoprotein and the risk of recurrent venous thromboembolism Circulation 115 2007 1609 1614 (Pubitemid 46648646)
12. T.C. Weng, Y.H. Yang, and S.J. Lin A systematic review and meta-analysis on the therapeutic equivalence of statins J Clin Pharm Ther 35 2010 139 151
13. S. Devaraj, E. Chan, and I. Jialal Direct demonstration of anti-inflammatory effect of simvastatin in subjects with the metabolic syndrome J Clin Endocrinol Metab 91 2006 4489 4496 (Pubitemid 44833428)
14. A. Undas, K.E. Brummel-Ziedins, and K.G. Mann Statins and blood coagulation Arterioscler Thromb Vasc Biol 25 2005 287 294 (Pubitemid 40189147)
15. M. Takemoto, and J.K. Liao Pleiotropic effects of 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitors Arterioscler Thromb Vasc Biol 21 2001 1712 1719 (Pubitemid 34219772)
16. R. Krysiak, B. Okopie, and Z.S. Herman Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes Drugs 63 2003 1821 1854 (Pubitemid 37083030)
17. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients BMJ 324 2002 71 86
18. R.J. Glynn, P.M. Ridker, and S.Z. Goldhaber Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial Ann Intern Med 147 2007 525 533 (Pubitemid 351664499)
19. S. Yusuf, F. Zhao, and S.R. Mehta Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
20. E.L. Eisenstein, K.J. Anstrom, and D.F. Kong Clopidogrel and long-term outcomes after drug-elution stent implantation JAMA 297 2007 159 168 (Pubitemid 46089732)
21. F.A. Anderson Jr, and F.A. Spencer Risk factors for venous thromboembolism Circulation 107 23 Suppl 1 2003 I9 I16
22. K. Lacut, E. Oger, and G. Le Gal Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study Fundam Clin Pharmacol 18 2004 477 482 (Pubitemid 39215361)
23. C.C. Yang, S.S. Jick, and H. Jick Statins and the risk of idiopathic venous thromboembolism Br J Clin Pharmacol 53 2002 101 105 (Pubitemid 34117746)
24. J.G. Ray, M. Mamdani, R.T. Tsuyuki, D.R. Anderson, E.L. Yeo, and A. Laupacis Use of statins and the subsequent development of deep vein thrombosis Arch Intern Med 161 2001 1405 1410 (Pubitemid 32681161)
25. A.S. Ramcharan, K.J. Van Stralen, and J.D. Snoep HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis J Thromb Haemost 7 2009 514 520
26. D.M. Herrington, E. Vittinghoff, and F. Lin Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS) Circulation 105 2002 2962 2967 (Pubitemid 34693827)
27. D. Khemasuwan, M.L. Divietro, and K. Tangdhanakanond Statins decrease the occurrence of venous thromboembolism in patients with cancer Am J Med 123 2010 60 65
28. P.M. Ridker, E. Danielson, and F.A. Fonseca Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
29. R.J. Glynn, E. Danielson, and F.A. Fonseca A randomized trial of rosuvastatin in the prevention of venous thromboembolism N Engl J Med 360 2009 1851 1861
30. A. Squizzato, M. Galli, and E. Romualdi Statins, fibrates, and venous thromboembolism: a meta-analysis Eur Heart J 31 2010 1248 1256
31. C.P. Cannon, B.A. Steinberg, and S.A. Murphy Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy J Am Coll Cardiol 48 2006 438 445 (Pubitemid 44109954)
32. A.G. Holst, G. Jensen, and E. Prescott Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study Circulation 121 2010 1896 1903
33. B.K. Mahmoodi, R.T. Gansevoort, N.J.G.M. Veeger Prevention of Renal and Vascular End-stage Disease (PREVEND) Study Group Microalbuminuria and risk of venous thromboembolism JAMA 301 2009 1790 1797
34. A.M. Chamberlain, A.R. Folsom, S.R. Heckbert, W.D. Rosamond, and M. Cushman High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE) Blood 112 2008 2675 2680
35. A. Szczeklik, M. Krzanowski, and P. Góra Antiplatelet drugs and generation of thrombin in clotting blood Blood 80 1992 2006 2011
36. R.J. Glynn, P.M. Ridker, and S.Z. Goldhaber Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial Ann Intern Med 147 2007 525 533 (Pubitemid 351664499)
37. M.T. Santos, M.P. Fuset, and M. Ruano Effect of Atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction Am J Cardiol 104 2009 1618 1623